IDEXX Laboratories Inc (IDXX)

Currency in USD
583.02
-1.03(-0.18%)
Real-time Data·
IDXX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
577.37585.38
52 wk Range
398.75769.98
Key Statistics
Prev. Close
584.05
Open
583.04
Day's Range
577.37-585.38
52 wk Range
398.75-769.98
Volume
205.35K
Average Vol. (3m)
521.72K
1-Year Change
44.3047%
Book Value / Share
20.1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IDXX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
742.54
Upside
+27.36%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

IDEXX Laboratories Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories Inc SWOT Analysis


Strategic Positioning
Learn about IDEXX's strong market position in veterinary diagnostics and software, and its strategies to maintain industry leadership
Analyst Projections
Average price target of $556, with estimates ranging from $481 to $630, reflecting varied views on IDEXX's growth potential
Innovation Pipeline
Discover how IDEXX's new product launches, including inVue Dx and Cancer Dx, are positioning the company for potential long-term growth
Market Resilience
Explore IDEXX's impressive financial metrics and stock performance amid veterinary visit fluctuations and macroeconomic challenges
Read full SWOT analysis

IDEXX Laboratories Inc Earnings Call Summary for Q4/2025

  • IDEXX Laboratories reported Q4 2025 revenue of $1.09 billion (14% YoY growth), exceeding forecasts, while EPS of $2.92 missed expectations by 0.34%, causing a 3.05% pre-market stock decline to $650.
  • The company maintains a premium valuation with a P/E ratio of 53.47, contributing to investor sensitivity despite strong financial metrics including free cash flow of $1.1 billion (100% of net income).
  • IDEXX expanded internationally in Germany, UK, Australia, and US markets while launching new diagnostic products, strengthening its position despite declining veterinary visits.
  • For 2026, management projects revenue between $4.632-4.72 billion with EPS guidance of $14.29-14.80 (10-14% growth) and expects 5,500 inVue Dx instrument placements.
  • CEO Jay Mazelsky emphasized IDEXX's strategic positioning to support evolving veterinary care through diagnostic and digital tools, highlighting software solutions as key growth drivers.
Last Updated: 02/02/2026, 09:44 AM
Read Full Transcript
IDEXX Labs investor slides for Q4/2025
IDEXX Q4 2025 slides
Last Update: Feb 02, 2026
See full investor slides

Compare IDXX to Peers and Sector

Metrics to compare
IDXX
Peers
Sector
Relationship
P/E Ratio
43.7x24.2x−0.5x
PEG Ratio
1.941.140.00
Price / Book
28.8x3.4x2.6x
Price / LTM Sales
10.7x2.4x3.2x
Upside (Analyst Target)
32.8%36.9%47.6%
Fair Value Upside
Unlock18.0%6.1%Unlock

Analyst Ratings

9 Buy
5 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 742.54
(+27.36% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Citi
Hold650.00+11.33%-New CoverageApr 15, 2026
Stifel
Buy675.00+15.61%775.00MaintainMar 31, 2026
UBS
Hold730.00+25.03%730.00MaintainMar 24, 2026
Piper Sandler
Hold750.00+28.46%775.00MaintainFeb 09, 2026
Barclays
Buy800.00+37.02%850.00MaintainFeb 05, 2026

Earnings

Latest Release
Feb 02, 2026
EPS / Forecast
2.92 / 2.93
Revenue / Forecast
1.09B / 1.07B
EPS Revisions
Last 90 days

IDXX Income Statement

People Also Watch

400.73
AXON
+5.22%
390.85
INTU
+6.56%
295.01
CEG
-0.54%
1,333.51
MPWR
-2.19%
516.42
STX
-3.19%

FAQ

What Is the IDEXX Labs (IDXX) Stock Price Today?

The IDEXX Labs stock price today is 583.02 USD.

What Stock Exchange Does IDEXX Labs Trade On?

IDEXX Labs is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for IDEXX Labs?

The stock symbol for IDEXX Labs is "IDXX."

What Is the IDEXX Labs Market Cap?

As of today, IDEXX Labs market cap is 46.39B USD.

What Is IDEXX Labs's Earnings Per Share (TTM)?

The IDEXX Labs EPS (TTM) is 13.08.

When Is the Next IDEXX Labs Earnings Date?

IDEXX Labs will release its next earnings report on May 05, 2026.

From a Technical Analysis Perspective, Is IDXX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has IDEXX Labs Stock Split?

IDEXX Labs has split 4 times.

How Many Employees Does IDEXX Labs Have?

IDEXX Labs has 11000 employees.

What is the current trading status of IDEXX Labs (IDXX)?

As of Apr 15, 2026, IDEXX Labs (IDXX) is trading at a price of 583.02 USD, with a previous close of 584.05 USD. The stock has fluctuated within a day range of 577.37 USD to 585.38 USD, while its 52-week range spans from 398.75 USD to 769.98 USD.

What Is IDEXX Labs (IDXX) Price Target According to Analysts?

The average 12-month price target for IDEXX Labs is 742.54 USD, with a high estimate of 823 USD and a low estimate of 470 USD. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +27.36% Upside potential.

What Is the IDXX Premarket Price?

IDXX's last pre-market stock price is 570.01 USD. The pre-market share volume is 30.00, and the stock has decreased by -14.04, or -2.40%.

What Is the IDXX After Hours Price?

IDXX's last after hours stock price is 585.00 USD, the stock has decreased by 0.95, or 0.16%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.